Role of exo- and endogeneous mesenchymal stem cells in liver ischemia reperfusion injury
Elke Eggenhofer(University Hospital Regensburg), MH Dahlke(University Hospital Regensburg), Philipp Renner(Robert Bosch Hospital), Volker Benseler(University of Regensburg), HJ Schlitt, EK Geissler(University Hospital Regensburg), FC Popp
Cited by 1
Related Papers
Mesenchymal stem cells are short-lived and do not migrate beyond the lungs after intravenous infusion
|Frontiers in Immunology|2012|820
Mesenchymal stem cells can induce long-term acceptance of solid organ allografts in synergy with low-dose mycophenolate
|Transplant Immunology|2008|198
Urinary Biomarkers TIMP-2 and IGFBP7 Early Predict Acute Kidney Injury after Major Surgery
|PLoS ONE|2015|169
Hepatocyte entry leads to degradation of autoreactive CD8 T cells
|Proceedings of the National Academy of Sciences|2011|162
Mesenchymal Stem Cells Require a Sufficient, Ongoing Immune Response to Exert Their Immunosuppressive Function
|Transplantation Proceedings|2009|124